Perimenopause: when your labs are “normal” and you are not.
The years of fluctuating hormones before the final period are where symptoms usually start, where standard tests mislead, and where good treatment helps most.
What perimenopause is
Perimenopause is the transition phase: ovarian function is declining but has not yet stopped — and the decline is not steady. Hormone levels swing unpredictably from week to week. A woman can have a normal hormone panel on Tuesday and a strikingly abnormal one the following month, even while her symptoms are obvious and unrelenting.
It typically begins in the 40s but can start earlier, and it is often where the most disruptive symptoms appear: irregular or heavier bleeding, hot flashes, fragmented sleep, mood changes, brain fog, joint aches. It is also the phase most often misdiagnosed — women are sent to a sleep specialist for insomnia, a psychiatrist for anxiety, a rheumatologist for joint pain, when one underlying hormonal shift is driving all of it.
Why “normal labs” don't settle it
For a woman over 45 with typical symptoms, guidelines are explicit: the diagnosis is clinical, and no blood test is required. FSH and estradiol fluctuate so much during this period that a single normal value does not rule perimenopause out. Diagnosis rests on age, cycle pattern, and symptoms — which is why the evaluation here starts with listening, in full, before any lab order.
How we treat the transition
Treatment during perimenopause is individualized: cycle-aware hormone therapy where appropriate, non-hormonal options where preferred or required, and attention to the thyroid, metabolic, and bone changes that begin in exactly these years. Because hormones are still swinging, dosing and follow-up matter more than in established menopause — a plan is set, monitored, and fine-tuned rather than prescribed and forgotten.